Roadshow
NeuroSwift Pro
Neurobit's primary products include NeuroSwift, a neurological diagnostic screening system that has received certifications from the U.S. FDA, EU CE MDR, and Taiwan TFDA for medical device approval. NeuroSwift Pro, designed for assessing central nervous and balance system disorders, is also FDA and TFDA certified. Additionally, the company offers the AIVertigo/NeuroSwift Pro+ system for brain disease classification and prediction, as well as eyeForm, a platform for predicting myopia risks.
Are you seeking innovative solutions to complex healthcare challenges? Visit us at MEDICA 2024 (Hall 16, Booth E02-2). We'll be demonstrating our cutting-edge technologies designed to improve patient outcomes and streamline healthcare processes.
#2024 MEDICA#TAIWAN PAVILION#TAIPEI
Neurobit Technologies Co., Ltd. was founded in Taipei, Taiwan. The company is structured into five main departments: Management, Sales, Manufacturing, Research & Development, and Quality Control. Neurobit Technology's core expertise includes high-interference-resistant eye-tracking technology, capable of outputting pupil center and gaze position with angular correction. The company also excels in report algorithm technology with self-calibration capabilities, ensuring data stability, as well as AIVertigo, a technology that aids in evaluating brain disorders.
- Company Neurobit Technologies Co., Ltd.
- Telephone 02-27710618
- Email info@neurobittech.com
- Address 2F, No. 320, Sec. 4, Zhongxiao E. Rd., Da'an Dist., Taipei City 106433, TAIWAN
Neurobit was founded by Travis Yang, Jim Huang, Ching-Fu Wang and Roger Chen while they were students at National Taiwan University. With the aim of providing revolutionary technology to the medical community, Neurobit integrated both hardware and software system which leverages artificial intelligence and machine learning for improved diagnostic precision that eases the lives of healthcare professionals around the globe.